Drug Discovery Solutions

  1. Phage And Yeast Display 6/5/2026

    Curia offers phage and eukaryotic-based yeast display platforms for in vitro discovery and engineering of potent antibody candidates for therapeutic or diagnostic use. High-affinity functional antibodies are routinely selected against a wide range of conventional or challenging targets (e.g. GPCRs) using customized or in-licensed state-of-the-art libraries.

  2. Recombinant Protein Production 5/28/2026

    Curia has decades of experience in recombinant protein production.

  3. In Vitro Biology 5/28/2026

    Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.

  4. Cell-Based Assay Development And Testing 5/28/2026

    Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.

  5. Medicinal Chemistry 5/28/2026

    Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.

  6. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  7. Molecular Biology 5/28/2026

    Our Biologics services provide comprehensive Molecular Biology services at facilities in California and Massachusetts, offering a variety of services.

  8. Protein Expression And Analysis 5/28/2026

    Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.

  9. Empowering The Future Of Medicine 2/23/2026

    Accelerate from development to commercialization with scalable manufacturing solutions. Integrated digital systems and expert technical advocacy ensure regulatory excellence and rapid batch release.

  10. Analytical Labs Particle Analysis

    Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.